Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Researchers show that benign, genetically engineered mosquitoes can outcompete disease-causing ones, suggesting a possible way to control the disease.
Bacteria have been genetically modified to kill the parasite that causes malaria, before people can be infected.
Brazil’s investment in transgenic animals shows how opposition to such technologies in the United States is opening opportunities elsewhere.
Collecting and analyzing information from simple cell phones can provide surprising insights into how people move about and behave—and even help us understand the spread of diseases.
Thanks to extensive genetic engineering, drugmakers can now brew large vats of the malaria drug artemisinin, stabilizing the world supply.
Location data suggests a better way to fight a disease that kills a million people a year.
MIT researchers gauge the progress of malaria using a novel imaging technique.
An MIT mechanical engineer has teamed up with molecular biologists to study the complex mechanisms behind diseased cells.